on Gastrointestinal Imaging:
暂无分享,去创建一个
K. | McNamara | A. Zaheer | I. Kamel | Joseph | L. Carucci | S. Asrani | Hina Arif-Tiwari | Goldstein | Pavan K. Srivastava | Nicole | Lilja | Mcnamara | Hindman | Michelle | Kamaya | M. | Grajo | Aya | R. | Kristin | Porter | Alan | Horowitz | Bjork. | Solnes | Jeanne | Victoria Chernyak | P. K. Srivastava
[1] J. Ward,et al. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease , 2021, Hepatology (Baltimore, Md.).
[2] A. Zaheer,et al. ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. , 2020, Journal of the American College of Radiology : JACR.
[3] Stephanie R. Wilson,et al. Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma , 2019, Abdominal Radiology.
[4] Kathryn J Fowler,et al. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI‐RADS) , 2019, Journal of magnetic resonance imaging : JMRI.
[5] Yu Shen,et al. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] P. Kamath,et al. Burden of liver diseases in the world. , 2019, Journal of hepatology.
[7] Yi Dong,et al. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings , 2018, BioMed research international.
[8] M. Huang,et al. Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response? , 2018, BioMed research international.
[9] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.
[10] E. Tapper,et al. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.
[11] M. Mazurowski,et al. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma. , 2018, AJR. American journal of roentgenology.
[12] M. Abecassis,et al. AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.
[13] C. Sirlin,et al. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis , 2018, Hepatology.
[14] Robert M. Marks,et al. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. , 2017, Clinical radiology.
[15] Wen-Pei Wu,et al. Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma. , 2017, Ultrasound in medicine & biology.
[16] Zixing Huang,et al. Gadoxetic acid disodium–enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta‐analysis , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] J. Marrero,et al. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US. , 2017, The American journal of medicine.
[18] M. Kudo,et al. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update , 2017, Hepatology International.
[19] Seth T. Lirette,et al. Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death. , 2017, Radiology.
[20] P. Pickhardt,et al. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. , 2016, AJR. American journal of roentgenology.
[21] S. Baik,et al. Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis , 2016, Gut and liver.
[22] T. Murakami,et al. Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe , 2015, Liver Cancer.
[23] Mohammad Hassan Murad,et al. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] Robert M. Marks,et al. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. , 2015, AJR. American journal of roentgenology.
[25] M. Ronot,et al. Imaging of benign hepatocellular lesions: current concepts and recent updates. , 2014, Clinics and research in hepatology and gastroenterology.
[26] Jin-Young Choi,et al. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. , 2014, Radiology.
[27] D. Marin,et al. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. , 2014, Radiology.
[28] Benjamin M Yeh,et al. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity. , 2013, AJR. American journal of roentgenology.
[29] Terry M. Therneau,et al. Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.
[30] B. Choi,et al. Comparison of Magnetic Resonance Elastography and Gadoxetate Disodium–Enhanced Magnetic Resonance Imaging for the Evaluation of Hepatic Fibrosis , 2013, Investigative radiology.
[31] M. Yoshikawa,et al. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. , 2013, Magnetic resonance imaging.
[32] P. Zhou,et al. Application of acoustic radiation force impulse imaging for the evaluation of focal liver lesion elasticity. , 2013, Hepatobiliary & pancreatic diseases international : HBPD INT.
[33] Bryce D. Smith,et al. Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma , 2013, Annals of Internal Medicine.
[34] R. Ehman,et al. Magnetic resonance elastography of liver: Technique, analysis, and clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.
[35] M. C. Chammas,et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. , 2013, Ultrasound in medicine & biology.
[36] S. Ahn,et al. Characterization of focal liver masses using acoustic radiation force impulse elastography. , 2013, World journal of gastroenterology.
[37] I. Kamel,et al. An Elevated Arterial Enhancement Fraction Is Associated With Clinical and Imaging Indices of Liver Fibrosis and Cirrhosis , 2012, Journal of computer assisted tomography.
[38] Alton B Farris,et al. Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium‐enhanced 3D gradient echo imaging , 2012, Journal of magnetic resonance imaging : JMRI.
[39] Hui Zhu,et al. Performance of magnetic resonance elastography and diffusion‐weighted imaging for the staging of hepatic fibrosis: A meta‐analysis , 2012, Hepatology.
[40] Myeong-Jin Kim,et al. Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. , 2012, The British journal of radiology.
[41] S. Kumano,et al. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT , 2012, Journal of Gastroenterology.
[42] R. Pozzi Mucelli,et al. Acoustic Radiation Force Impulse (ARFI) ultrasound imaging of solid focal liver lesions. , 2012, European journal of radiology.
[43] Kuni Ohtomo,et al. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. , 2011, European journal of radiology.
[44] Noriyuki Moriyama,et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. , 2011, Radiology.
[45] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[46] D. Lu,et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[47] M. Kudo. Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress , 2010, Oncology.
[48] Giovanni Vizzini,et al. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants , 2010, European Radiology.
[49] T. Kim,et al. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound. , 2009, European journal of radiology.
[50] J. Bruix,et al. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star. , 2009, Gastroenterology.
[51] Yun Yen,et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[52] Gunda Millonig,et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis , 2008, Hepatology.
[53] G. Fattovich,et al. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and α-fetoprotein levels , 2008, La radiologia medica.
[54] Ze-Zhou Song. Acute viral hepatitis increases liver stiffness values measured by transient elastography , 2008, Hepatology.
[55] M. Hashizume,et al. Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications , 2008, Journal of gastroenterology and hepatology.
[56] J. Bruix,et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.
[57] K. Jhaveri,et al. Value of the Unenhanced Phase for Detection of Hepatocellular Carcinomas 3 cm or Less When Performing Multiphase Computed Tomography in Patients With Cirrhosis , 2007, Journal of computer assisted tomography.
[58] Sheng-Nan Lu,et al. Small hepatic nodules (≤2 cm) in cirrhosis patients: characterization with contrast‐enhanced ultrasonography , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[59] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[60] P. Roderick,et al. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.
[61] S. Paggi,et al. Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. , 2005, World journal of gastroenterology.
[62] L. Oğuzkurt,et al. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. , 2005, European journal of radiology.
[63] H. Hussain,et al. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially‐enhancing liver mass , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[64] Carlo Catalano,et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. , 2005, Radiology.
[65] D. Mitchell,et al. Right posterior hepatic notch sign: A simple diagnostic MR finding of cirrhosis , 2003, Journal of magnetic resonance imaging : JMRI.
[66] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[67] Hisham Tchelepi,et al. Sonography of Diffuse Liver Disease , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[68] M. Laeeq Khan,et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.
[69] E L Murphy,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[70] L. Beretta,et al. Cirrhosis: diagnosis with sonographic study of the liver surface. , 1989, Radiology.
[71] W. Alexander,et al. European Association for the Study of the Liver , 1968 .
[72] Claude B. Sirlin,et al. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid , 2016, Abdominal Radiology.
[73] Benjamin M Yeh,et al. Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. , 2013, Radiology.
[74] V. Mazzaferro,et al. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .
[75] J. Kao,et al. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients , 2011, European Radiology.
[76] D. Harnois,et al. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .
[77] Steven Solga,et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? , 2009, Journal of hepatology.
[78] Irccs Ospedale. Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C , 2005 .
[79] V. Šimonovský. The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. , 1999, The British journal of radiology.
[80] J. Emparanza,et al. [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.
[81] Anru Zhang,et al. [A prospective study of early detection for primary liver cancer]. , 1996, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[82] M. Bernardino,et al. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. , 1986, Journal of computer assisted tomography.